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We report a 57-year-old man with acute thrombocytopenia, leucopenia, and multiorgan dysfunction. Patient was from North
Korea and was temporarily working in Dubai, United Arab Emirates, when he fell ill in March 2009. At the same time and
unknown to us, many patients with similar clinical manifestations were admitted to hospitals in China. The Chinese cases—
identiﬁed between March and July 2009—were recently reported to have been infected with a tick-born strain of bunyavirus, a
new disease. The virus infection was documented in patients from central China and the region that shares the border with North
Korea. The clinical manifestations, the time of disease onset, and geographical link of the patient with the region in which the
disease is endemic suggest that the patient had SFTS bunyavirus infection.
1.Introduction
Severe fever and thrombocytopenia syndrome (SFTS) is
a newly identiﬁed disease in China that is caused by a
strain of bunyavirus. The disease is characterized by fever,
thrombocytopenia, leucopenia, bleeding, and multiorgan
dysfunction and has 30% mortality rate. It is transmitted by
a tick and has not been reported outside China. The clinical
and epidemiological description of the disease in English
literature is sparse [1].
2. Case Presentation
A previously healthy 57-year-old North Korean male work-
ing in Dubai, United Arab Emirates (UAE), developed an
acute hemorrhagic stroke in March 2009. There was no
history of trauma, abuse of tobacco or alcohol, exposure to
toxic fumes or dust, or traveling outside UAE during the
last 12 months. On physical examination he was drowsy and
moving all four extremities. Temperature was normal, blood
pressure 220/116mmHg, and heart rate 98 per minute. CT
scan of the brain showed thalamic hemorrhage with blood
extension into the ventricular system and CT angiography
showed no evidence of an aneurysm. The patient was intu-
bated,chesttubewasplacedbecauseofaleftpneumotoraxat
the time of intubation. Blood pressure required control with
labetololonlyforinitialfewdays.Onadmission,hemoglobin
was 16.6g/dL, neutrophils 8.9 × 109/L, lymphocytes 0.8
× 109/L and platelets 130 × 109/L. Within 48h, patient
developed fever, severe neutropenia, thrombocytopenia, and
a more profound lymphocytopenia (Figure 1) and skin and
lung bleeding. Coagulation tests were normal. Bone marrow
examination ﬁndings are shown in Figure 2.T o x i cs c r e e n
was negative. The ﬂow cytometry disclosed normal CD8
and low CD3, CD4, and CD19 cell counts; IgG level was
decreased. Pneumonia and K. pneumoniae sepsis developed
but there was no evidence of disseminated intravascular
coagulation, hemolysis or renal impairment. Treatment with
Tazocine,immunoglobulins,granulocyte-colonystimulating
factor, steroids, and interleukin-11 was commenced. CT
scan of the chest showed bilateral pneumothorax, lung
bullae, and consolidation; however, blood oxygenation of2 Case Reports in Infectious Diseases
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Figure 1: Blood cell counts during hospitalization. Abbreviations:
IL-11: interleukin-11; G-CSF: granulocyte-colony stimulating fac-
tor; Imm.Glob: human immunoglobulins.
the patient was relatively good throughout hospital stay
and serum activity of alpha-1-antitrypsin was normal.
Tests for systemic lupus erythematosus, antiphospholipid
syndrome and c- and p-ANCA were negative. Tests for
HIV1, HIV2, cytomegalovirus, Epstein-Barr virus, herpes
simplex virus, and Mycoplasma pneumoniae infection were
all negative on admission and three weeks later. Infection
with Legionella pneumophila was excluded with negative
urine test for its antigen. During the third and fourth weeks
of hospitalization the patient had hepatitis and myositis.
Acute hepatitis A, B, and C infections were excluded with
repeated serological tests and the tests for Dengue and
Crimean-Congo hemorrhagic fever (CCHF) were negative.
In the fourth week of hospital stay, patient had complete
quadriplegia with preserved sensation of pain and touch.
Paralytic ileus developed due to autonomic neuropathy and
was treated conservatively. Electroneuromyographic study
disclosed evidence of axonal motor radiculoneuropathy and
cerebrospinal ﬂuid examination showed ﬁndings consistent
with aseptic meningitis. Repeated doses of immunoglobulin
were given and the patient began to recover. On the 60th
hospital day, his motor power was 4/5 and improving, all
cell counts and biochemical tests were normal, and he was
discharged home.
3. Discussion
Clinical manifestations in our patient are best explained
with a systemic viral infection and, on epidemiological and
clinical grounds, it likely was SFTS bunyavirus.
3.1. Epidemiology. Our patient had clinical manifestations
similar to those in patients with SFTS bunyavirus infection.
The onset of his disease (March 2009) occurred simulta-
neously with the onset of epidemic of SFTS bunyavirus
infection in China (March–July 2009). In addition, some
of the Chinese patients were from the Liaoning province
that share border with North Korea [1]. Thus clinical
presentation and spatiotemporal epidemiology of patient’s
illness suggest that he had SFTS bunyavirus infection. Our
patient did not report history of tick bite but the absence
of history of tick bite is common in patients with diseases
transmitted by ticks. The absence of history of recent travel
to home country is a missing link in this case. Incubation
period and duration of the persistence of the virus in
the body is yet unknown. Although human to human
transmission of SFTS was not reported previously, it cannot
be excluded altogether; other tick-borne bunyaviruses may
be parenterally transmitted via body ﬂuids and tissue, in
settings that provide close contacts of people. Our patient
resided abroad with his fellow countrymen in a densely
populated environment created for temporary workers in
which men periodically come from and go to their home
country. In such environment, the transmission of infectious
agent by direct contact may be possible; in the past, this
occurred with CCHF in Dubai, another bunyavirus infection
[2]. Similarly, import of infected tick from home country
cannotbeexcludedasarthropod-bornediseasesspreadmore
readily within the deprived populations [3].
3.2. Clinical Manifestations. The full spectrum of clinical
manifestations of SFTS is not well documented in English
language literature. Cerebral hemorrhage in the patient could
have been due to a virus-induced vasculitis [4–6]. Vasculitis
associated with ANCA autoantibodies was excluded with
negative tests [7]. CT angiography may not detect small
vasculitic changes and the absence of aneurysm does not
exclude vasculitis. Hypertension in our patient is an unlikely
cause of cerebral hemorrhage and more likely an immediate
reactiontoanincreasedintracerebralpressurefrombleeding;
patient subsequently neither had hypertension nor the signs
of its preexistence. Transient thrombocytopenia, neutropenia,
and lymphocytopenia were most likely the consequence of
virus infection as well because evidence does not support
otherpossiblecauses:multisystemdiseases,drugs,andtoxins
[8]. Bone marrow ﬁndings are also consistent with viral
infection (Figure 2). Several viral infections could produce
lymphocytopenia and low IgG level via “cytokine storm”
that is also associated with a depression of granulocyte and
monocyte counts, both decreased in our patient [9–14].
Bacterialsepsisinthepatientcouldproduceneutropeniaand
thrombocytopenia but this is excluded by the presence of
cytopenias prior to the development of bacterial infection.
Similarly, stroke-induced immunosuppression may produce
neutropenia but thrombocytopenia, myositis, hepatitis and
Guillain-Barre neuropathy are not part of this syndrome
[15]. Acute hepatitis and myositis c o u l db ec a u s e db ys e v e r a l
types of viruses but repeated tests for those agents were neg-
ative. The type and doses of medications which were given to
the patient are not strongly associated with the development
of hepatitis, and myositis. Similarly, K. pneumoniae infection
is unlikely a cause of myositis [16–18]. Further, there was
no evidence of primary multisystem diseases that could
cause hepatitis and myositis. Consequently, unidentiﬁedCase Reports in Infectious Diseases 3
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Figure 2: Bone marrow study: (a) mild hypocellularity. (b) Positive histiocytes stain for CD68 marker. (c) Myeloid cell line composed
mostly of promyelocytes with prominent Golgi apparatus and absent neutrophils and metamyelocytes (maturation arrest). (d) Histiocytes
and promyelocyte (center) with a rare histiocyte showing hemophagocytosis.
virus becomes the most likely etiology of hepatitis and
myositis. Acute motor axonal neuropathy type of Guillain-
Barr´ es y n d r o m ewas present in our patient and was related
in the past to several bacterial and viral infections. However,
none of our repeated tests were positive for these infections.
Further, Guillain-Barr´ e syndrome was reported in patient
with suppressed immune function by drugs, HIV, and
CMV but those causes were excluded in our transiently
immunocompromised patient [19].
In summary, clinical manifestations in our patient are
best explained by systemic viral infection. We did not ﬁnd
in literature such a combination of manifestations in a
single patient. The presence of acute thrombocytopenia,
neutropenia, lymphocytopenia, bleeding, and multiorgan
dysfunction was all reported in patients with SFTS bun-
yavirus infection [1]. The absence of high fever on admission
argues against SFTS in our patient. However, temperature
increased once thrombocytopenia and leucopenia developed
despite administration of steroids.
4. Conclusion
Clinical manifestations and spatiotemporal epidemiology of
the disease suggest diagnosis of SFTS bunyavirus infection.
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